Statistics for CASI Pharmaceuticals Inc (id:5858 CASI)

Valuation metrics

Market cap

58.75M

Enterprise value

77.80M

Trailing P/E (ttm)

-1.88

Forward P/E

-1.78

PEG ratio

-1.78

Price/Sales (ttm)

2.54

Price/Book (mrq)

2.10

Enterprise Value/Revenue

3.37

Enterprise Value/EBITDA

-3.37

Overview

Shares outstanding

15.46M

Float

5.95M

Shares short

75.57K

% Held by insiders

0.48%

% Held by institutions

0.26%

Average volume (10 days)

44.03K

Average volume (90 days)

Price summary

52-Week low

2.05

52-Week high

8.48

52-Week change

-47.10%

Beta

0.65

50-Day moving average

5.64

200-Day moving average

4.93

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

June 2, 2022

Financials

Fiscal year

Fiscal year ends

December 31, 2023

Most recent quarter (mrq)

September 30, 2024

Profitability

Profit margin

-117.68%

Operating margin

-240.11%

Operational effectiveness

Return on assets

-26.60%

Return on equity

-85.43%

Income statement

Revenue (ttm)

1.72

Revenue per share (ttm)

1.72

Quarterly revenue growth (yoy)

Gross profit (ttm)

20.05M

EBITDA

-23,079,500.00

Net income to common (ttm)

-27,205,000.00

Diluted EPS (ttm)

-2.23

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

12.73M

Total cash per share (mrq)

0.94

Total debt (mrq)

18.46M

Total Debt/Equity (mrq)

204.69

Current ratio (mrq)

388.10%

Book value per share (mrq)

1.81

Cash flow

Cash flow statement

-21,056,000.00

Levered free cash flow (LFCF)

-38,482,500.00